GGrantIndex
← Search

CD4 Redirected Chimeric Antigen Receptor T Cell Therapy for CD4 Positive T Cell Neoplasms

$526,876R01FY2020FDFDA

Indiana University Indianapolis, Indianapolis IN

Investigators

View original record on NIH RePORTER →